Literature DB >> 28338466

Surrogate end points save lives.

Christopher Vinden1.   

Abstract

SUMMARY: Patient-centric markers are important, and when they can be conveniently measured they should dominate research questions. However, when the research question pertains to serious or potentially fatal illnesses and it will take years or even decades to answer with patient-centric outcomes, then a pragmatic approach based on common sense and surrogate markers should be adopted. This commentary discusses the important role that surrogate markers can play in medical research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28338466      PMCID: PMC5373719          DOI: 10.1503/cjs.013916

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  5 in total

1.  Screening for colorectal cancer: recommendation and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

2.  Recommendations on screening for colorectal cancer in primary care.

Authors: 
Journal:  CMAJ       Date:  2016-02-22       Impact factor: 8.262

Review 3.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Jennifer S Lin; Margaret A Piper; Leslie A Perdue; Carolyn M Rutter; Elizabeth M Webber; Elizabeth O'Connor; Ning Smith; Evelyn P Whitlock
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

4.  Cancer statistics, 1996.

Authors:  S L Parker; T Tong; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1996 Jan-Feb       Impact factor: 508.702

Review 5.  Are outcomes reported in surgical randomized trials patient-important? A systematic review and meta-analysis.

Authors:  Sam Adie; Ian A Harris; Justine M Naylor; Rajat Mittal
Journal:  Can J Surg       Date:  2017-04       Impact factor: 2.089

  5 in total
  1 in total

1.  Toward a "New School" of surgical research.

Authors:  Vivian McAlister
Journal:  Can J Surg       Date:  2017-08       Impact factor: 2.089

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.